维普中文期刊产品整合服务
16篇 您的检索式:作者名="ZAMANI O"
    题名 作者 年代 出处 被引量
1A phaseⅢ,randomized,placebo-controlled study of belimumab,a monoclonal antibodythat inhibits B lymphocyte stimulator,in patients withsystemic lupus erythematosus显示文摘Furie R Petri M Zamani O 2011Arthritis Rheum2011,63,12:1
2A phaseⅢ,randomized,placebo-controlled study of belimumab,a monoclonal antibody that inhibits B lymphocyte stimulator,in patients with systemic lupus erythematosus显示文摘Furie R Petri M Zamani O 2011Arthritis Rheum2011,63,12:1
3A phase Ⅲ, ran domized, placebo-controlled study of belimumah, a mono clonal antibody that inhibits B lymphocyte stimulator, in pa tients with systemic lupus erythematosus显示文摘FURIE R PETRI M ZAMANI O 2011Arthritis and Rheumatism2011,63,12:1
4A phase Ⅲ,randomized,placebo-controlled study of belimumab,a monoclonal antibody that inhibits B lymphocyte stimulator,in patients with systemic lupus erythematosus显示文摘Furie R Petri M Zamani O 2011Arthritis Rheum2011,63,12:1
5A phase III, random- ized, placebo-controlled study of belimumab, a mono- clonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus 显示文摘Furie R Petri M Zamani O 2011Arthritis Rheumatism2011,63,12:1
6Effects of hot water treatments on antioxidant enzymatic system in reducing flesh browning of persimmon 显示文摘Khademi O Salvador A Zamani Z 2012Food and Bioprocess Technology2012,,:1
7A phase III, randomized, pla- cebo-controlled study of belimumab, a monoclonal antibody that in- hibits B lymphocyte stimulator, in patients with systemic lupus ery- thematosus显示文摘Furie R Petri M Zamani O 2011Arthritis Rheum2011,,63:1
8A phase lII, randomized, pla- cebo-controlled study of belimumab, a monoelonal antihody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus显示文摘Furie R Petri M Zamani O 2011Arthritis Rheum2011,63,:1
9Occupational exposure to pesticides and consequences on male semen and fertility: a review显示文摘Mehrpour O Karrari P Zamani N 2014Toxicol Lett2014,230,2:1
10A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus显示文摘Furie R Petri M Zamani O 2011Arthritis Rheum2011,63,12:1
11A phase III, randomized, place- bo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythemato- sus 显示文摘Furie R Petri M Zamani O 2011Arthritis Rheum2011,63,12:1
12A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with system- ic lupus erythematosus显示文摘Furie R Petri M Zamani O 2011Arthritis Rheum2011,63,12:1
13A phase El , randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits Blymphocyte stimulator, in patients with systemic lupus erythematosus显示文摘Furie R Petri M Zamani O 2011Arthritis Rheum2011,63,12:1
14A phase III, randomized, place- bo - controlled study of belimumab, a monoclonal antibody that in- hibits B lymphocyte stimulator, in patients with systemic lupus ery- thematosus显示文摘Furie R Petri M Zamani O 2011Arthritis Rheum2011,12,:1
15Occupational exposure to pesticides and consequences on male semen and fertility:a review显示文摘Mehrpour O Karrari P Zamani N 2014Toxicol Lett2014,230,2:1
16A phase , randomized, placebo- controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus显示文摘Furie R Petri M Zamani O 2011Arthritis Rheum2011,12,63:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费